Independence Group NL

Similar documents
Oz Minerals. Solid start to the year A$5.62 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Oz Minerals. On track to meet guidance A$6.51 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Platinum Asset Management

Sandfire Resources. Swings to net cash A$5.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Kingsgate Consolidated

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

SG Fleet Group. Another UK acquisition. Earnings and target price revision

Perseus Mining. Revised Sissingué plan A$0.31 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

Oz Minerals. Raises copper production outlook A$9.08 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

Regis Resources. Strong 1H15 result A$1.29 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

NIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.

Pilbara Minerals (PLS AU) Ramp-up gaining traction

Oil Search. Proving up PNG A$7.11 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

PanAust. Larger impairment and dividend cut A$1.35 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Automotive Holdings Group

Orocobre. Upside exposure fading. Earnings and target price revision. Price catalyst. Catalyst: Update on projects or Q1 report

Ramsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Sandfire Resources. Strong result but guidance light A$6.10 AUSTRALIA. Event. Impact. Earnings and target price revision.

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Sims Metal Management

Whitehaven Coal. China outlook drives impairments A$1.04 AUSTRALIA. Event. Impact. Earnings and target price revision.

Newcrest Mining. Strong production result A$21.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Fisher & Paykel Healthcare

Tox Free Solutions. Winning work again A$2.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

National Australia Bank

Silver Lake Resources

Sirtex Medical. Healthy dose sales. Earnings and target price revision. Price catalyst. Catalyst: FY16 result on the 24th of August

Cochlear. Roberts replaced A$88.66 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Senex Energy Production and revenue unsurprised, cash builds on lower capex

Saracen Mineral Holdings

Doray Minerals. Mine life upside at Andy Well A$0.44 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Bendigo and Adelaide Bank

Southern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA

Coca-Cola Amatil. Not as fizzy as it looks A$8.78 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Origin Energy. 4Q Production. ORG reported its 4 th quarter production report, following on ConocoPhilips quarterly result.

Evolution Mining. Cowal pushes EVN beyond 800kozpa A$1.10 AUSTRALIA. Event. Impact. Earnings and target price revision.

Meridian Energy. On tax depreciation NZ$2.08 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Nuplex Industries. Should benefit from a weak Kiwi NZ$4.55 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation

Karoon Gas. What a difference a day makes A$1.63 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

NEW ZEALAND Price Valuation NZ$ 1.74 Event 12-month target NZ$ month TSR % -10.1

ANZ Bank. The Dis-Associates. Earnings and target price revision. No change. Price catalyst. Catalyst: 3Q15 Trading Update. Action and recommendation

Telstra Corporation. Vodafone better, but far from good A$6.43 AUSTRALIA. Event. Impact. Earnings and target price revision.

CIMIC Group. Earnings and target price revision. No change. Price catalyst. Catalyst: Q1 earnings 13 April. Action and recommendation

Fisher & Paykel Healthcare

Super Retail Group (SUL AU) Are we there yet?

Iluka Resources. A soft start to FY15 A$7.73 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Fortescue Metals Group

BHP Billiton. Mad Dog 2 gets FID AUSTRALIA/ UNITED KINGDOM/ SOUTH AFRICA. Event. Impact. Earnings and target price revision.

Spotless Group Holdings

Vista Group International

Kiwi Property Group. Land banking for the future NZ$1.43 NEW ZEALAND. Event. Impact. Earnings and target price revision.

MMG. A year of consolidation in 2017 AUSTRALIA/HONG KONG. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Generation Healthcare REIT

Downer EDI Two out of three ain t bad Event

Healthcare. Currency adjustments AUSTRALIA. Event. Impact. Outlook COH 8.0% RMD 6.9% CSL 6.0% ANN 5.0% SHL 2.6%

Genworth Mortgage Insurance Australia

Fortescue Metals Group

Auckland International Airport

Carsales.com. Motoring along nicely A$10.23 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

AUSTRALIA Price Valuation A$ 7.52 Event 12-month target A$ month TSR % +3.4

Fortescue Metals Group

Premier Investments. Making a move? A$14.18 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Ramsay Health Care (RHC AU) RHC UK on the mend?

SingTel. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Outperform.

Fortescue Metals Group

Iron Mountain. US$10 worth Recalling at investor day US$31.83 UNITED STATES. Event. Impact. Earnings and target price revision.

SingTel. Optus rises A$3.98 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Dexus Property Group. Infra driving industrial demand A$9.94 AUSTRALIA. Event. Impact. Earnings and target price revision.

Rio Tinto. Mixed production, but iron-ore in line AUSTRALIA/UNITED KINGDOM A$48.99/ Event. Impact. Earnings and target price revision

Australian Mid-cap Iron-Ore

Fortescue Metals Group

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation

Genesis Energy. A 9% FCF yield and you call underperform? NZ$1.71 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Adelaide Brighton. Overcoming headwinds A$5.45 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Rio Tinto. Expect more cash back in RIO AU/RIO LN Outperform AUSTRALIA/UNITED KINGDOM. Event. Impact. Earnings and target price revision

ANZ Bank. What execution risk? Earnings and target price revision. Price catalyst. Catalyst: 1Q17 Trading update, February 2017.

Karoon Gas. Losing the deal A$1.83 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Ryman Healthcare. Arrested development NZ$9.60 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst

Aussie Macro Moment. Budget 16/17 careful consolidation AUSTRALIA. Event. Impact. Outlook

3P Learning. Coming to America... A$2.55 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Australian Mobile Market

Fisher & Paykel Healthcare

South32. Klipspruit coal mine tour AUSTRALIA/ UNITED KINGDOM/ SOUTH AFRICA. Event. Impact. Earnings and target price revision.

Aust. General Insurance

Asaleo Care. NZ$ pulped. We review the outlook for Asaleo. Earnings and target price revision. Price catalyst. Catalyst: CY15 results.

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook

National Australia Bank

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Nine Entertainment Co.

Australian Banks. Funding markets open for now

Australian Banks. Money Talks vertically challenged AUSTRALIA. Inside. Majors average short positions and banks index

AMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Transcription:

AUSTRALIA IGO AU Price (at 12:29, 26 Oct 216 GMT) Outperform A$4.25 Valuation A$ - DCF (WACC 8.4%, beta 1.2, ERP 5.%, RFR 3.3%) 3.98 12-month target A$ 5. 12-month TSR % +2.2 Volatility Index High GICS sector Materials Market cap A$m 2,493 3-day avg turnover A$m 11.8 Number shares on issue m 586.7 Investment fundamentals Year end 3 Jun 216A 217E 218E 219E Revenue m 411.6 574.1 936.6 977.3 EBIT m 4.8 45.6 259. 295.2 Reported profit m -58.8 25.1 178. 212.1 Adjusted profit m 41.9 25.1 178. 212.1 Gross cashflow m 161.3 175.2 415.5 45.1 CFPS 36. 29.8 7.7 76.6 CFPS growth % -56.9-17.2 137.2 8.3 PGCFPS x 11.8 14.3 6. 5.5 PGCFPS rel x 1. 1.43.66.67 EPS adj 9.3 4.3 3.3 36.1 EPS adj growth % -69.9-54.3 68.8 19.2 PER adj x 45.5 99.5 14. 11.8 PER rel x 2.29 6.1.98.96 Total DPS 2. 1 13. 15. Total div yield %.5 2.4 3.1 3.5 Franking % 1 1 1 1 ROA % 2.9 2.1 1.8 11.8 ROE % 3.9 1.6 1 11.1 EV/EBITDA x 13.3 13.9 5.5 5.1 Net debt/equity % 15.1 9.9-7.7-25. P/BV x 1.3 1.4 1.4 1.3 IGO AU vs Small Ordinaries, & rec history Note: Recommendation timeline - if not a continuous line, then there was no Macquarie coverage at the time or there was an embargo period. Source: FactSet, Macquarie Research, October 216 (all figures in AUD unless noted) 27 October 216 Macquarie Securities (Australia) Limited First concentrate at Nova Event IGO has announced that first copper and nickel concentrates have been produced at Nova, overshadowing a soft 1QFY17 production result. Impact Headline production result was mixed: IGO s 1QFY17 production result was mixed with a strong performance form Jaguar and Long offset by a weaker result at Tropicana. Jaguar s production result was strong with zinc output 1% higher and copper production 54% better than expected. Long s production result was 8% better than we expected but costs were also higher. Tropicana reported 5% weaker production but also lower cash and AISC costs. Earnings result weaker than expected: The mixed production result combined with delayed shipments at both Jaguar and Tropicana resulted in unaudited revenue and Ebitda for the quarter of A$95m and A$38m, 12% and 6% lower than we had forecast, respectively. The weaker revenue result, which was recovered in October, resulted in net debt of A$22m at the end of September, above our A$11m forecast. Nova production commences: Having announced construction completion and ore commissioning in early October Nova produced its first nickel and copper concentrates on 26 October. As we outlined in our deep dive, we expected Nova to commence production ahead of schedule hence the early production announcement was not much of a surprise. First concentrate shipments to Nickel West are expected to occur in the December quarter. Long Island study the next major catalyst: Technical studies for the Long Island project are expected to be completed by the end of the year. We expect the study will include a major reserve and resource upgrade at Tropicana, as the study will incorporate 1km of drilling completed over the past 12 months. Earnings and target price revision Earnings change less than 1% after incorporating the 1QFY17 production report and our A$5. price target is unchanged. Price catalyst 12-month price target: A$5. based on a 5/5 NPV/7.x EV/Ebitda methodology. Catalyst: The release of the Long Island study later this year presents a material catalyst for IGO. Action and recommendation Maintain Outperform: IGO s 1QFY17 production result was slightly weaker than we had expected, however all operating projects remain on target to hit production guidance for FY17. The commencement of production at Nova ahead of schedule was expected with the release of the Long Island study the next major catalyst for IGO. Please refer to page 6 for important disclosures and analyst certification, or on our website www.macquarie.com/research/disclosures.

1QFY17 production Tropicana produced 1koz in the 1QFY17, 5% lower than we had expected. Lower mill throughput and recoveries were the key drivers behind the softer result and the average grade was slightly higher than forecast. Gold sales for the quarter of 88koz, well below production and 16% lower than we had expected. Cash costs were slightly better than we had forecast despite the lower gold sales, due to lower capex and inventory adjustments. Long production of 2.17kt was 8% higher than we had forecast with the production beat due to higher average grades. Cash costs of A$3.23/lb were 8% lower than we had forecast due to lower mining costs and also favourable quotational pricing adjustments. Jaguar delivered an impressive quarter, with in-line zinc production of 1.3kt boosted by a 54% beat in copper output of 1.89kt. The higher copper by-product credits resulted in cash costs coming in 25% below our forecasts. However like Tropicana lower sales compared to production resulted in revenue from Jaguar coming in below our forecasts. Fig 1 Mixed production result Quarterly Result Macq Actual Variance Long Nickel production (kt) 2. 2.17 8% Cash costs (A$/lb) 3.5 3.23 (8%) Jaguar Zinc production (kt) 1.2 1.31 1% Copper production (kt) 1.22 1.89 54% Cash costs (A$/lb).69.52 (25%) Tropicana Gold production (koz) 15.4 1 (5%) Cash costs (A$/oz) 946 95 (4%) AISC (A$/oz) 1,188 1,97 (8%) Source: IGO, Macquarie Research, October 216 Lower gold sales at Tropicana and a delayed shipment from Jaguar resulted in revenue for the quarter missing our forecast by 12%. This was partially offset by inventory adjustments, however Ebitda and net profit were 6% and 35% lower than we were anticipating, respectively. The weaker earnings result translated to net debt coming in ~A$11m higher than anticipated. Fig 2 Lower revenue drove lower earnings and cash flow Quarterly Result Macq Actual Variance Revenue (A$m) 17.8 94.8 (12%) Ebitda (A$m) 4.6 38.1 (6%) Net Profit (A$m) 15.4 1.1 (35%) Cash at bank (A$m) 229.1 249. 9% Net cash / (debt) (A$m) (1.9) (22.) 12% Source: IGO, Macquarie Research, October 216 Modest changes to earnings We have made only modest adjustments to our earnings forecast after incorporating the 1QFY17 production result. The lack of earnings impact reflect the revenue catch-up at Tropicana and Jaguar that is expected to occur in the 2QFY17. Our $5. price target remains unchanged. Fig 3 Modest changes to earnings Quarterly Result FY17e FY18e FY19e FY2e NPV Net profit (A$m) - old 25 178 213 228 5. Net profit (A$m) - new 25 178 212 225 5. Change (%) % (1%) (1%) % Source: IGO, Macquarie Research, October 216 27 October 216 2

Fig 4 Tropicana production and costs Fig 5 Long production and costs 5 Tropicanca (koz) Cash costs (A$/oz) 45 4 35 3 25 2 15 1,2 1, 8 6 4 12. 1 8. 6. 4. Nickel mined (kt) Cash costs (A$lb) 5. 4.5 4. 3.5 3. 2.5 2. 1.5 1 5 2 2. 1..5 Source: IGO, Macquarie Research, October 216 Source: IGO, Macquarie Research, October 216 Fig 6 Jaguar production and costs Fig 7 Nova production and costs Copper in conc (kt) Zinc in conc (kt) 35. Nickel in conc (kt) Copper in conc (kt) 5 Cash costs (A$/lb).9 3 Cash costs (A$/lb) AISC (A$/lb) 45..8 4.7 25. 35..6 2 3.5 25. 15..4 2 1.3 15. 1.2 5. 5..1 FY11 FY12 FY13 FY14 FY15 FY16 FY17e FY18e FY19e Source: IGO, Macquarie Research, October 216 Source: IGO, Macquarie Research, October 216 5. 4.5 4. 3.5 3. 2.5 2. 1.5 1..5 Fig 8 IGO net cash vs. market cap Fig 9 IGO NPV by project 3, 2,5 2, Net cash (A$m) Market Cap (A$m) Long 5% Jaguar 5% 1,5 1, 5 Nova 5% Tropicana 39% -5-1, 216 217 218 219 22 221 222 223 224 225 Stockman 1% Source: IGO, Macquarie Research, October 216 Source: IGO, Macquarie Research, October 216 27 October 216 3

Fig 1 IGO summary financials Independence Group ASX: IGO Price: (A$ps) 4.25 Year end: Jun Rating: Outperform Up/dn TSR Mkt cap: (A$m) 2,493 Diluted shares (m) 586.7 Target: 5. 18% 2% ASSUMPTIONS FY14 FY15 FY16 FY17e FY18e FY19e FY2e ATTRIBUTABLE MINE OUTPUT FY14 FY15 FY16 FY17e FY18e FY19e FY2e Exchange Rate (A$/US$).92.84.73.75.72.73.74 Nickel Production (equity) Nickel price (US$/lb) 6.91 7. 4.23 4.91 5.67 6.12 6.58 Long kt 1.9 1.2 8.5 8.2 8.1 8.2 8.9 Gold price (US$/oz) 1,296 1,223 1,167 1,327 1,394 1,381 1,438 AISC US$/lb 5.52 4.47 3.65 2.82 2.99 3.9 2.72 RATIO ANALYSIS FY14 FY15 FY16 FY17e FY18e FY19e FY2e Nova kt 9.8 28.1 29. 27.1 Diluted share capital m 235.3 236.4 448.1 587.8 587.8 587.8 587.8 AISC US$/lb nm nm nm 3.27 1.23 1.31 1.47 EPS (diluted and pre sig. items) A 33.4 31.1 9.3 4.3 3.3 36.1 38.3 Zinc/Copper production (equity) P/E x 12.7x 13.7x 45.5x 99.5x 14.x 11.8x 11.1x Zinc kt 41.2 45. 39.3 4.9 38.4 38.4 51.7 CFPS A 65.3 69. 18.9 17.3 77.3 83.9 75.5 Copper kt 7.7 7.4 7.4 5.6 4.4 4.4 12.9 P/CF x 6.5x 6.2x 22.5x 24.6x 5.5x 5.1x 5.6x Net Cash Cost (per pay lb Zn) US$/lb.29.36.34.5.54.59.59 DPS A 8. 8.5 2. 1 13. 15. 12. Gold production (equity) Dividend yield % 1.9% 2.%.5% 2.4% 3.1% 3.5% 2.8% Tropicana koz 14.4 148.9 134.4 124.8 126.4 126.4 126.4 Franking Level % 1% 1% 1% 1% 1% 1% 1% All in Cash Cost (US$/oz) US$/oz 682 673 678 86 844 822 851 Book value per share x 2.92 2.81 3.25 2.94 3.13 3.35 3.57 EBITDA BY PROJECT P/Book value x 1.5x 1.5x 1.3x 1.4x 1.4x 1.3x 1.2x 6 Long (A$m) Jaguar (A$m) Tropicana (A$m) Stockman (A$m) Nova (A$m) R.O.E. (pre sig items) % 11% 11% 3% 1% 1% 11% 11% R.O.A. (pre sig items) % 12% 13% 2% 2% 11% 11% 12% 5 Interest Cover x 22.9x 628.6x -6.4x 3.9x 54.8x -37.6x -17.4x EBITDA per share A$ps.74.87.31.33.84.9.91 4 EV/EBITDA x 14.1x 11.6x 19.3x 13.8x 4.8x 3.8x 3.2x FCF Yield % 1% 5% (13%) (8%) 15% 17% 15% 3 EARNINGS FY14 FY15 FY16 FY17e FY18e FY19e FY2e 2 Sales Revenue A$m 398 494 412 574 937 977 985 Other Revenue A$m 1 4 1 Total Revenue A$m 398 495 416 574 937 977 985 Operating Costs A$m (28) (234) (226) (368) (432) (436) (437) Operational EBITDA A$m 19 261 189 26 55 542 548 FY13 FY14 FY15 FY16 FY17e FY18e FY19e FY2e Exploration Expense/Write-offs A$m (4) (25) (2) (3) (2) (2) (2) RESERVES AND RESOURCES (ATTRIBUTABLE) Corporate & Other Costs A$m (12) (3) (29) (1) (8) (8) (9) Nickel reserves EBITDA A$m 174 25 14 192 494 531 538 Project (kt) Mt % Ni Ni (kt) D&A A$m (7) (99) (1) (147) (235) (236) (233) Long.4 3.9% 14 EBIT A$m 14 17 41 46 259 295 34 Nova 13.6 2.% 275 Net Interest A$m (5) () 1 (12) (5) 8 17 Total nickel reserves (kt) 14. 2.1% 289 Profit Before Tax A$m 1 17 41 34 254 33 322 Nickel resources Tax Expense A$m (21) (33) (9) (76) (91) (97) Project (kt) Mt % Ni Ni (kt) Minorities A$m Long 1.3 4.7% 6 Adjusted NPAT A$m 79 74 42 25 178 212 225 Nova 14.3 2.3% 325 Significant Items (post tax) A$m (32) 3 (11) Total nickel resources (kt) 15.6 2.5% 385 Reported NPAT A$m 47 77 (59) 25 178 212 225 Gold reserves Project (kt) Mt g/t Au Au (koz) Tropicana (IGO share) 12.3 1.8 723 CASHFLOW FY14 FY15 FY16 FY17e FY18e FY19e FY2e Total gold reserves (koz) 12.3 1.8 723 Net Profit A$m 47 77 (59) 25 178 212 225 Gold Resources Interest/Tax/D&A A$m 92 119 82 126 293 284 216 Project (kt) Mt g/t Au Cu (kt) Working Capital/other A$m 15 (33) 61 (49) (17) (2) 3 Tropicana (IGO share) 37.4 1.9 2,244 Net Operating Cashflow A$m 154 163 85 12 454 493 444 Total gold resources (koz) 37.4 1.9 2,244 Capex A$m (123) (6) (29) (222) (78) (61) (65) Copper reserves Investments A$m () 13 (24) (76) Project (kt) Mt % Cu Cu (kt) Sale of PPE and Other A$m Jaguar 1.4 1.2% 17 Free cash flow A$m 3 116 (328) (195) 377 432 379 Nova 14.3.8% 113 Dividends Paid A$m (9) (26) (13) (29) (65) (82) (94) Total copper reserves (kt) 15.7.8% 13 Debt A$m 9 (29) 265 (66) (2) Copper Resources Equity Issuance A$m 274 Project (kt) Mt % Cu Cu (kt) Other A$m Jaguar 3.7 1.3% 48 Net Financing Cashflow A$m () (54) 252 179 (265) (82) (94) Nova 14.3.9% 134 Net change in cash A$m 3 61 (76) (16) 112 35 286 Total copper resources (kt) 18. 1.% 182 EQUITY DCF VALUATION Spot prices Macquarie forecasts Projects A$m A$ps A$m A$ps BALANCE SHEET FY14 FY15 FY16 FY17e FY18e FY19e FY2e Long 74.13 127.22 Cash A$m 57 121 46 3 142 492 777 Jaguar 78.13 12.2 PP&E & Mine Development A$m 412 351 1,518 1,668 1,511 1,336 1,167 Tropicana 87 1.48 949 1.62 Exploration A$m 187 11 18 137 155 173 191 Stockman 26 4 26 4 Total Assets A$m 891 82 2,7 2,344 2,437 2,568 2,629 Nova 732 1.24 1,198 2.4 Debt A$m 28 1 266 2 Undeveloped Resources 159.27 159.27 Total Liabilities A$m 24 155 552 618 598 599 529 Unpaid capital Total Net Assets / Equity A$m 687 665 1,456 1,726 1,839 1,969 2,1 Corporate/forwards (52) (9) (55) (9) Net Debt / (Cash) A$m (29) (121) 22 17 (142) (492) (777) Net cash (debt) (189) (.32) (188) (.32) Gearing (net debt/(nd + equity)) % (4%) (22%) 13% 9% (8%) (33%) (59%) Net Equity Value (@ 9% WACC) 1,697 2.89 2,337 3.98 Gearing (net debt/equity) % (4%) (18%) 15% 1% (8%) (25%) (37%) Price Target (5/5 Blend NPV (1.4x for gold) and 7x (FY18) EV/Ebitda) (1x NPV) 5. Source: IGO, Macquarie Research, October 216 27 October 216 4

Macquarie Quant View The quant model currently holds a strong negative view on Independence Group NL. The strongest style exposure is Price Momentum, indicating this stock has had strong medium to long term returns which often persist into the future. The weakest style exposure is Quality, indicating this stock is likely to have a weaker and less stable underlying earnings stream. 142/1521 Global rank in Materials % of BUY recommendations 22% (4/18) Number of Price Target downgrades Number of Price Target upgrades 4 Fundamentals Attractive Quant Local market rank Global sector rank Displays where the company s ranked based on the fundamental consensus Price Target and Macquarie s Quantitative Alpha model. Two rankings: Local market (Australia & NZ) and Global sector (Materials) Macquarie Alpha Model ranking A list of comparable companies and their Macquarie Alpha model score (higher is better). Factors driving the Alpha Model For the comparable firms this chart shows the key underlying styles and their contribution to the current overall Alpha score. 1..9.2-1.3-1. -3. -2. -1. 1. 2. 3. -1% -8% -6% -4% -2% % 2% 4% 6% 8% 1% Valuations Growth Profitability Earnings Momentum Price Momentum Quality Macquarie Earnings Sentiment Indicator The Macquarie Sentiment Indicator is an enhanced earnings revisions signal that favours analysts who have more timely and higher conviction revisions. Current score shown below. Drivers of Stock Return Breakdown of 1 year total return (local currency) into returns from dividends, changes in forward earnings estimates and the resulting change in earnings multiple..1.1.3 -.2-3. -2. -1. 1. 2. 3. -1% -5% % 5% 1% Dividend Return Multiple Return Earnings Outlook 1Yr Total Return What drove this Company in the last 5 years Which factor score has had the greatest correlation with the company s returns over the last 5 years. Price to Book FY1 Price to Book LTM Price to Book NTM 25d Volatility Return on Equity NTM Return on Equity FY1 Net Income Margin NTM Operating Margin NTM Negatives Positives -18% -19% -19% -21% 24% 21% 28% 27% -3% -2% -1% % 1% 2% 3% How it looks on the Alpha model A more granular view of the underlying style scores that drive the alpha (higher is better) and the percentile rank relative to the sector and market. Alpha Model Score Valuation Growth Profitability Earnings Momentum Price Momentum Quality Capital & Funding Liquidity Risk Technicals & Trading Normalized Score -1.33 -.89 -.41 -.56 -.11.32-1.39-1.28 -.9 -.86 -.36 Percentile relative to sector(/1521) Percentile relative to market(/423) 5 1 5 1 1 1 Source (all charts): FactSet, Thomson Reuters, and Macquarie Research. For more details on the Macquarie Alpha model or for more customised analysis and screens, please contact the Macquarie Global Quantitative/Custom Products Group (cpg@macquarie.com) 27 October 216 5

Important disclosures: Recommendation definitions Macquarie - Australia/New Zealand Outperform return >3% in excess of benchmark return Neutral return within 3% of benchmark return Underperform return >3% below benchmark return Benchmark return is determined by long term nominal GDP growth plus 12 month forward market dividend yield Macquarie Asia/Europe Outperform expected return >+1% Neutral expected return from -1% to +1% Underperform expected return <-1% Macquarie South Africa Outperform expected return >+1% Neutral expected return from -1% to +1% Underperform expected return <-1% Macquarie - Canada Outperform return >5% in excess of benchmark return Neutral return within 5% of benchmark return Underperform return >5% below benchmark return Macquarie - USA Outperform (Buy) return >5% in excess of Russell 3 index return Neutral (Hold) return within 5% of Russell 3 index return Underperform (Sell) return >5% below Russell 3 index return Volatility index definition* This is calculated from the volatility of historical price movements. Very high highest risk Stock should be expected to move up or down 6 1% in a year investors should be aware this stock is highly speculative. High stock should be expected to move up or down at least 4 6% in a year investors should be aware this stock could be speculative. Medium stock should be expected to move up or down at least 3 4% in a year. Low medium stock should be expected to move up or down at least 25 3% in a year. Low stock should be expected to move up or down at least 15 25% in a year. * Applicable to Asia/Australian/NZ/Canada stocks only Recommendations 12 months Note: Quant recommendations may differ from Fundamental Analyst recommendations Financial definitions All "Adjusted" data items have had the following adjustments made: Added back: goodwill amortisation, provision for catastrophe reserves, IFRS derivatives & hedging, IFRS impairments & IFRS interest expense Excluded: non recurring items, asset revals, property revals, appraisal value uplift, preference dividends & minority interests EPS = adjusted net profit / efpowa* ROA = adjusted ebit / average total assets ROA Banks/Insurance = adjusted net profit /average total assets ROE = adjusted net profit / average shareholders funds Gross cashflow = adjusted net profit + depreciation *equivalent fully paid ordinary weighted average number of shares All Reported numbers for Australian/NZ listed stocks are modelled under IFRS (International Financial Reporting Standards). Recommendation proportions For quarter ending 3 September 216 AU/NZ Asia RSA USA CA EUR Outperform 47.26% 55.5% 38.46% 45.47% 59.9% 48.21% (for US coverage by MCUSA, 8.2% of stocks followed are investment banking clients) Neutral 38.1% 29.31% 42.86% 48.77% 37.88% 36.79% (for US coverage by MCUSA, 8.25% of stocks followed are investment banking clients) Underperform 14.73% 15.19% 18.68% 5.76% 3.3% 15.% (for US coverage by MCUSA, 8.% of stocks followed are investment banking clients) IGO AU vs Small Ordinaries, & rec history (all figures in AUD currency unless noted) Note: Recommendation timeline if not a continuous line, then there was no Macquarie coverage at the time or there was an embargo period. Source: FactSet, Macquarie Research, October 216 12-month target price methodology IGO AU: A$5. based on a 5/5 NPV/7.x EV/Ebitda methodology Company-specific disclosures: IGO AU: The Macquarie Group together with its affiliates, beneficially owns 1% or more of a class of common equity securities of Independence Group (IGO.AX) MACQUARIE CAPITAL (AUSTRALIA) LIMITED or one of its affiliates managed or co-managed a public offering of securities of Independence Group NL in the past 12 months, for which it received compensation. The analyst principally responsible for the preparation of this report or a member of the analyst's immediate household holds exercises investment discretion over a long position in Windward Resources Ltd, which has received a takeover offer from. Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/research/disclosures. Date Stock Code (BBG code) Recommendation Target Price 14-Oct-216 IGO AU Outperform A$5. 7-Sep-216 IGO AU Outperform A$4.8 19-Jul-216 IGO AU Underperform A$3.9 11-Jul-216 IGO AU Neutral A$4. 6-Jul-216 IGO AU Neutral A$3.7 15-Jun-216 IGO AU Neutral A$3.1 19-May-216 IGO AU Neutral A$3.15 17-May-216 IGO AU Neutral A$3. 28-Apr-216 IGO AU Neutral A$3.3 15-Mar-216 IGO AU Neutral A$3.4 18-Feb-216 IGO AU Outperform A$3.3 17-Dec-215 IGO AU Outperform A$3.15 14-Dec-215 IGO AU Outperform A$3.1 3-Oct-215 IGO AU Outperform A$4.1 24-Sep-215 IGO AU Outperform A$4.3 29-Jul-215 IGO AU Outperform A$5. 24-Jul-215 IGO AU Outperform A$5.3 27 October 216 6

This publication was disseminated on 26 October 216 at 13:33 UTC. Macquarie Wealth Management 16-Jul-215 IGO AU Outperform A$5.4 26-May-215 IGO AU Outperform A$5.6 13-May-215 IGO AU Outperform A$6.2 9-Apr-215 IGO AU Outperform A$6.3 21-Mar-215 IGO AU Outperform A$6.5 18-Feb-215 IGO AU Outperform A$6. 15-Jan-215 IGO AU Outperform A$5.9 4-Dec-214 IGO AU Outperform A$5.5 29-Oct-214 IGO AU Outperform A$5.55 28-Aug-214 IGO AU Outperform A$5.4 22-Aug-214 IGO AU Outperform A$5.2 28-Jul-214 IGO AU Outperform A$5.5 21-Jul-214 IGO AU Outperform A$5.25 16-May-214 IGO AU Outperform A$5.1 28-Apr-214 IGO AU Outperform A$5. 9-Apr-214 IGO AU Outperform A$4.85 4-Mar-214 IGO AU Outperform A$4.8 27-Nov-213 IGO AU Outperform A$4.6 31-Oct-213 IGO AU Outperform A$4.7 Target price risk disclosures: IGO AU: Any inability to compete successfully in their markets may harm the business. This could be a result of many factors which may include geographic mix and introduction of improved products or service offerings by competitors. The results of operations may be materially affected by global economic conditions generally, including conditions in financial markets. The company is exposed to market risks, such as changes in interest rates, foreign exchange rates and input prices. From time to time, the company will enter into transactions, including transactions in derivative instruments, to manage certain of these exposures. Analyst certification: We hereby certify that all of the views expressed in this report accurately reflect our personal views about the subject company or companies and its or their securities. We also certify that no part of our compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. The Analysts responsible for preparing this report receive compensation from Macquarie that is based upon various factors including Macquarie Group Limited (MGL) total revenues, a portion of which are generated by Macquarie Group s Investment Banking activities. General disclosure: This research has been issued by Macquarie Securities (Australia) Limited ABN 58 2 832 126, AFSL 238947, a Participant of the ASX and Chi-X Australia Pty Limited. This research is distributed in Australia by Macquarie Wealth Management, a division of Macquarie Equities Limited ABN 41 2 574 923 AFSL 23754 ("MEL"), a Participant of the ASX, and in New Zealand by Macquarie Equities New Zealand Limited ( MENZ ) an NZX Firm. Macquarie Private Wealth s services in New Zealand are provided by MENZ. Macquarie Bank Limited (ABN 46 8 583 542, AFSL No. 23752) ( MBL ) is a company incorporated in Australia and authorised under the Banking Act 1959 (Australia) to conduct banking business in Australia. None of MBL, MGL or MENZ is registered as a bank in New Zealand by the Reserve Bank of New Zealand under the Reserve Bank of New Zealand Act 1989. Apart from Macquarie Bank Limited ABN 46 8 583 542 (MBL), any MGL subsidiary noted in this research,, is not an authorised deposit-taking institution for the purposes of the Banking Act 1959 (Australia) and that subsidiary s obligations do not represent deposits or other liabilities of MBL. MBL does not guarantee or otherwise provide assurance in respect of the obligations of that subsidiary, unless noted otherwise. This research contains general advice and does not take account of your objectives, financial situation or needs. Before acting on this general advice, you should consider the appropriateness of the advice having regard to your situation. We recommend you obtain financial, legal and taxation advice before making any financial investment decision. This research has been prepared for the use of the clients of the Macquarie Group and must not be copied, either in whole or in part, or distributed to any other person. If you are not the intended recipient, you must not use or disclose this research in any way. If you received it in error, please tell us immediately by return e-mail and delete the document. We do not guarantee the integrity of any e-mails or attached files and are not responsible for any changes made to them by any other person. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any transaction. This research is based on information obtained from sources believed to be reliable, but the Macquarie Group does not make any representation or warranty that it is accurate, complete or up to date. We accept no obligation to correct or update the information or opinions in it. Opinions expressed are subject to change without notice. The Macquarie Group accepts no liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. The Macquarie Group produces a variety of research products, recommendations contained in one type of research product may differ from recommendations contained in other types of research. The Macquarie Group has established and implemented a conflicts policy at group level, which may be revised and updated from time to time, pursuant to regulatory requirements; which sets out how we must seek to identify and manage all material conflicts of interest. The Macquarie Group, its officers and employees may have conflicting roles in the financial products referred to in this research and, as such, may effect transactions which are not consistent with the recommendations (if any) in this research. The Macquarie Group may receive fees, brokerage or commissions for acting in those capacities and the reader should assume that this is the case. The Macquarie Group s employees or officers may provide oral or written opinions to its clients which are contrary to the opinions expressed in this research. Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/disclosures Macquarie Group 27 October 216 7